NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

georgebailey,

To tell you the truth there are a few things that 700,000 extra pages could be focused on. First of all this trial started as de novo GBM then turned to GBM and rGBM. As you know GBM was reclassified based on IDH status too before results were published so plenty of things this extra paperwork could represent. The possibilities also includes supporting evidence of tissue agnostic status due to the natural in vivo way DCs and, therefore, DCVax works through the imitation of the process of DC maturation/activation and subsequent immune response in almost ALL DISEASES. Then there is the use of Poly ICLC as an activator of increased immune response and digitization of Edens which will be the answer, at least on an early interim basis, for getting a personalized vaccine treatment to the masses of patients wanting and needing them. Take your pick, they are all good choices. Best wishes,